438 filings
Page 3 of 22
8-K
jnflqj5
5 May 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:01pm
DEFA14A
e6iahpg0dvripvd0
28 Apr 23
Additional proxy soliciting materials
3:03pm
EFFECT
4udz7e ivxdaqfo3sn2s
14 Apr 23
Notice of effectiveness
12:15am
8-K
pp00dt6 t8h
13 Apr 23
Submission of Matters to a Vote of Security Holders
4:05pm
CORRESP
qu0ja14
13 Apr 23
Correspondence with SEC
12:00am
8-K
9r5k2lw3c21f
30 Mar 23
Fortress Biotech Reports Record 2022 Financial Results and Recent Corporate Highlights
5:28pm
UPLOAD
f93eci0dyn2t9597
15 Feb 23
Letter from SEC
12:00am
8-K
tm54a3m
9 Feb 23
Fortress Biotech Announces Pricing of $13.9 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
5:03pm
424B5
zcth3v89vitb
9 Feb 23
Prospectus supplement for primary offering
4:40pm
8-K
1sx8ws1akljaizuz
19 Dec 22
Fortress Biotech Appoints Lucy Lu, M.D., to its Board of Directors
8:26am
8-K
qvzthgxmbb hlwd0p1
14 Nov 22
Fortress Biotech Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights
5:02pm
8-K
i1rtb12l
4 Nov 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:06pm